Teijin Limited et al v. Aurobindo Pharma Ltd. et al
| Teijin Limited, Teijin Pharma Limited and Takeda Pharmaceuticals U.S.A., Inc. |
| Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. |
| 1:2017cv01314 |
| September 15, 2017 |
| US District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Vacant Judgeship (2017) |
| Mary Pat Thynge |
| Patent - Abbreviated New Drug Application |
| 35 U.S.C. ยง 271 |
| None |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
